相关实验视频

Updated: Feb 19, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

在TAVR患者中的巴特尔指数 - - 一个新的使用旧得分

Magda Haum^1,2, Lukas Weyde³, Julius Steffen^3,4

¹Medizinische Klinik Und Poliklinik I, Klinikum Der Universität München, LMU München, LMU Klinikum, Marchioninistr. 15, Munich, 81377, Germany. Magda.haum@med.uni-muenchen.de.

Clinical research in cardiology : official journal of the German Cardiac Society

|February 17, 2026

概括

巴特尔指数 (BI) 可以预测通过导管大动脉置换 (TAVR) 进行大动脉狭窄后的长期存活率. 较低的BI分数表明脆弱性,并且与TAVR后的生存率显著降低有关.

科学领域:

心脏病学心脏病学
老年病的医生老年病的医生
干预心脏病学干预心脏病学

背景情况:

过导管大动脉置换 (TAVR) 是对大动脉狭窄症 (AS) 的标准治疗方法.
精确的患者选择对于优化老年TAVR患者长期结果至关重要.
巴特尔指数 (BI) 评估日常生活活动和功能状态.

研究的目的:

评估巴特尔指数 (BI) 在TAVR后长期存活的预后价值.
确定BI是否可以识别可能从TAVR中受益较少的脆弱患者.
评估BI和STS分数对死亡率的综合预测能力.

主要方法:

一个单一中心对475名接受TAVR治疗的患者进行了回顾性分析,以治疗严重症状的AS.
根据BI分数,患者被分为两组:较高的BI (≥90) 和较低的BI (<90).
两组之间的长期存活率进行了比较,并分析了BI和STS死亡率得分的预测准确性.

主要成果:

较低BI分数的患者年龄较大,手术风险较高 (STS分数),功能较差.
在4年后的长期存活率在较低的BI组 (53.1%) 与较高的BI组 (80.0%) 相比显着较低.
与单独的STS得分相比,将STS得分与BI得分结合起来可以改善死亡率预测 (C指数为0.683比0.626).

结论:

巴特尔指数 (BI) 是大动脉狭窄症TAVR后长期生存的强有力的预测指标.
BI有效地识别了在手术后的前四年内具有较高死亡风险的脆弱患者.
应考虑BI作为严重AS患者TAVR前评估的一部分.

关键词:

大动脉狭窄症大动脉狭窄症巴瑟尔指数巴瑟尔指数风险评分风险评分风险评分在TAVRR中,我们可以看到.

更多相关视频

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

相关概念视频

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...